Search for cancer therapies could be transformed by innovative technique
the ONA take:
Researchers based at the University of Illinois have now developed a technique to pinpoint novel, medically relevant products produced created by bacteria. Many companies have steered away from natural product discovery due to the difficulties developing new products, but using their new technique, the investigators quickly has success developing a novel product derived from soil bacteria. Soil bacteria has been historically a good source, as it produces antibiotics to repel competitors.
The investigators used genomics to screen the soil bacteria in their search for novel antibiotic products. As the screening takes place, compounds of interest are tagged for review. The tags add mass, allowing the researchers to detect the compounds via mass spectrometry. (The most popular method typically used to identify novel products is bioassay-guided isolation, which has the tendency to produce similar results on repeated trials by "rediscovering" the most active or abundant compounds to the exclusion of the rarer compounds, which go unnoticed.) The sensitivity of mass spectrometry allows for novel products present at lower abundance.
Research results was reported in the journal ACS Chemical Biology.
Search for new cancer therapies could be transformed by innovative technique
In a study reported in ACS Chemical Biology, University of Illinois researchers developed a new technique to quickly uncover novel, medically relevant products produced by bacteria.
Past techniques involved screening more than 10,000 samples to find a novel product, said principal investigator Doug Mitchell, assistant professor of chemistry and Institute for Genomic Biology (IGB) member.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis
- GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible
- Annual Screening of High-Risk Smokers Only More Cost-effective Than Current Methods
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|